A previous study on breast cancer cells demonstrated that ITGB2-AS1 expression could elevate ITGB2 (i.e., CD18) mRNA and protein levels [43], aligning with our correlation network from transcriptomic datasets of eosinophilic-related diseases (Figure 1B). This evidence concerns the gene ITGB2 and breast cancer.